DRUG · Mapped RxNorm record
Ramipril
Normalized identity: ramipril View linked drug · Find medicine records ·
Find other trials using this name
Clinical trial
Ramipril and Clopidogrel in Oxidative Stress, Vascular Inflammation and Endothelial Dysfunction in Type 2 Diabetes and Diabetic Nephropathy
NCT01743014
Study summary
ClinicalTrials.govRamipril and Clopidogrel in Oxidative Stress, Vascular Inflammation and Endothelial Dysfunction in Type 2 Diabetes and Diabetic Nephropathy
Design: INTERVENTIONAL · Status: UNKNOWN · Phase: PHASE4
Loading study purpose, treatment groups and outcomes…
View the complete registry record, eligibility and contacts at ClinicalTrials.gov
Drugs and interventions used in this trial
2 registeredThese interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.
DRUG · Mapped RxNorm record
Clopidogrel
Normalized identity: clopidogrel View linked drug · Find medicine records ·
Find other trials using this name
No matching interventions in this trial.
Advertisement
Conditions
Diabetes Type 2candidate · MONDO: type 2 diabetes mellitus
Vascular Diseaseunresolved
Interventions
RamiprilDRUG · verified · RxNorm: ramipril
ClopidogrelDRUG · verified · RxNorm: clopidogrel
Sponsors & collaborators
AHEPA University Hospitallead sponsor
Aristotle University Of Thessalonikicollaborator
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT01743014 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.